AI/ML technologies are revolutionizing pharmaceutical formulation by optimizing excipient selection and predicting stability, reducing time and resources needed for development. Poor solubility of ...

An AI lab notebook now integrates validated third-party scientific applications used across biopharma R&D. The approach keeps analysis, reasoning, and results in one experimental record while enabling ...

In-silico modeling aids in early decision-making for poorly soluble drugs, which are prevalent in development pipelines. AI, ML, and statistical algorithms guide ...